MTS Issues an Important Message to its Shareholders prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast
The Stock Day Podcast welcomed Lexaria Bioscience Corp. a company with the proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.Jolly began the interview by congratulating Bunka on the Company’s Nasdaq Capital Market uplisting, which was announced on January 12th, …
The Stock Day Podcast welcomed Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) (“the Company”), a company with the proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.